Orange Book product · Generic (ANDA)
THALIDOMIDE
THALIDOMIDE
Generic (ANDA)ANDA 213267TE ABRX NATCO
At a glance
Apr 24, 2026
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 24, 2026
2 mo ago
Today
Pharmaceutical detail
Active ingredient
THALIDOMIDE
Strength
50MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 213267
Product number
002
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of THALIDOMIDE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
